Skip to main content
. 2022 Feb 21;115(5):728–736. doi: 10.1007/s12185-022-03305-z

Fig. 2.

Fig. 2

Boxplots showing anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody titers in patients treated with cytotoxic chemotherapy alone or with CD20 antibodies or Bruton’s tyrosine kinase inhibitor (BTKi) within 6 months of their last treatment and thereafter